China NT Pharma Group Company Limited (1011.HK) HKSE

0.81

+0(+0.00%)

Updated at October 17 03:43PM

Currency In HKD

Valuation

Market Cap66.97M
Enterprise Value433.3M
P/E Ratio-5.85
PEG Ratio0.39
Price/Sales Ratio26.84
Price/Book Ratio-1.5
Enterprise/Revenue43.57
Enterprise/EBITDA-110.57

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-3.8
Operating Margin-0.64

Management Effectiveness

Return On Assets-0.21
Return On Equity0.21

Income Statement

Revenue37.96M
Revenue/Share0.03
Gross Profit5.26M
EBITDA-8.65M
Net Income-53.36M
Diluted EPS-0.2

Balance Sheet

Total Cash4.63M
Total Cash/Share0.01
Total Debt316.72M
Total Debt/Equity-1.14
Current Ratio0.05
Book Value Per Share-0.5

Price History

52-Week Change105.06
52-Week High1.35
52-Week Low0.19
Moving Average 50 Days0.94
Moving Average 200 Days0.5

Statistics

Average Volume2.01M
Shares Outstanding674.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJuly 18, 2024